Correlation Between Molecular Partners and Addex Therapeutics
Can any of the company-specific risk be diversified away by investing in both Molecular Partners and Addex Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Molecular Partners and Addex Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Molecular Partners AG and Addex Therapeutics, you can compare the effects of market volatilities on Molecular Partners and Addex Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Molecular Partners with a short position of Addex Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Molecular Partners and Addex Therapeutics.
Diversification Opportunities for Molecular Partners and Addex Therapeutics
0.32 | Correlation Coefficient |
Weak diversification
The 3 months correlation between Molecular and Addex is 0.32. Overlapping area represents the amount of risk that can be diversified away by holding Molecular Partners AG and Addex Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Addex Therapeutics and Molecular Partners is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Molecular Partners AG are associated (or correlated) with Addex Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Addex Therapeutics has no effect on the direction of Molecular Partners i.e., Molecular Partners and Addex Therapeutics go up and down completely randomly.
Pair Corralation between Molecular Partners and Addex Therapeutics
Given the investment horizon of 90 days Molecular Partners AG is expected to generate 0.79 times more return on investment than Addex Therapeutics. However, Molecular Partners AG is 1.27 times less risky than Addex Therapeutics. It trades about 0.02 of its potential returns per unit of risk. Addex Therapeutics is currently generating about 0.0 per unit of risk. If you would invest 592.00 in Molecular Partners AG on November 29, 2024 and sell it today you would lose (107.00) from holding Molecular Partners AG or give up 18.07% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Molecular Partners AG vs. Addex Therapeutics
Performance |
| Timeline |
| Molecular Partners |
| Addex Therapeutics |
Molecular Partners and Addex Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Molecular Partners and Addex Therapeutics
The main advantage of trading using opposite Molecular Partners and Addex Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Molecular Partners position performs unexpectedly, Addex Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Addex Therapeutics will offset losses from the drop in Addex Therapeutics' long position.| Molecular Partners vs. Mineralys Therapeutics, Common | Molecular Partners vs. AN2 Therapeutics | Molecular Partners vs. Pharvaris BV | Molecular Partners vs. PepGen |
| Addex Therapeutics vs. Innate Pharma | Addex Therapeutics vs. Aptorum Group Ltd | Addex Therapeutics vs. Dyadic International | Addex Therapeutics vs. Soligenix |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments |